Pfizer raises full-year guidance on non-Covid products
FROM THE WIRE · FINANCE.YAHOO.COM
Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and acquired products. Continue Reading
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA guidance raise by a major pharma company can move the healthcare sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Pfizer raised its full-year guidance.
- 02The growth comes from non-Covid products and acquired products.
- 03The company benefits from its latest quarter results.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Pfizer Inc.30.00 USDMarket closedtoday -2.18%Positive S&P 5007,568.71Market closedtoday +0.36%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets